{{Rsnum
|rsid=12565755
|Chromosome=1
|position=60576203
|Orientation=plus
|GMAF=0.1419
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 2.7 | 20.4 | 77.0
| HCB | 5.1 | 45.3 | 49.6
| JPT | 16.8 | 45.1 | 38.1
| YRI | 0.0 | 0.7 | 99.3
| ASW | 0.0 | 14.0 | 86.0
| CHB | 5.1 | 45.3 | 49.6
| CHD | 5.5 | 38.5 | 56.0
| GIH | 1.0 | 17.8 | 81.2
| LWK | 0.0 | 0.9 | 99.1
| MEX | 1.7 | 17.2 | 81.0
| MKK | 0.0 | 3.8 | 96.2
| TSI | 1.0 | 17.6 | 81.4
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22491018
|Trait=None
|Title=Genome-wide association analysis implicates the involvement of eight loci with response to tocilizumab for the treatment of rheumatoid arthritis.
|RiskAllele=
|Pval=5E-8
|OR=0.3900
|ORtxt=None
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}